Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
58.6M
-
Number of holders
-
99
-
Total 13F shares, excl. options
-
23.6M
-
Shares change
-
+2.99M
-
Total reported value, excl. options
-
$1.08B
-
Value change
-
+$140M
-
Put/Call ratio
-
2.89
-
Number of buys
-
70
-
Number of sells
-
-32
-
Price
-
$45.82
Significant Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock (AGIO) as of Q2 2014
115 filings reported holding AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock as of Q2 2014.
AGIOS PHARMACEUTICALS, INC. - Common Stock (AGIO) has 99 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 23.6M shares
of 58.6M outstanding shares and own 40.23% of the company stock.
Largest 10 shareholders include FMR LLC (5.09M shares), Third Rock Ventures, LLC (3.9M shares), Flagship Ventures 2007 General Partner LLC (1.93M shares), LORD, ABBETT & CO. LLC (1.2M shares), Capital World Investors (1.13M shares), WELLINGTON MANAGEMENT CO LLP (1.09M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.02M shares), VANGUARD GROUP INC (859K shares), BlackRock Fund Advisors (704K shares), and BB Biotech AG (506K shares).
This table shows the top 99 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.